Inventor · disambiguated record
Rebecca Hutcheson
Also filed as: HUTCHESON REBECCA
9 granted patents·6 pending applications·14 citations·filing 2018–2025
84Inventor score
Files withSHY Therapeutics LLC15
Top patents by PatentIndex Score
15 records- 0190US11026930B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2020·Granted Jun 8, 2021·2 cites·16 claims
- 0288US10588894B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2018·Granted Mar 17, 2020·4 cites·6 claims
- 0386US10940139B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 9, 2021·3 cites·27 claims
- 0485US11000515B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted May 11, 2021·2 cites·58 claims
- 0584US10933054B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 2, 2021·2 cites·30 claims
- 0681US2023149369A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 0778US12391705B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Aug 19, 2025·1 cites·27 claims
- 0878US11541041B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 3, 2023·0 cites·39 claims
- 0976US11213515B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 4, 2022·0 cites·33 claims
- 1071US12459951B2Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2024·Granted Nov 4, 2025·0 cites·46 claims
- 1169US2025296938A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2025·Application pending·0 cites
- 1264US2025289825A1Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2025·Application pending·0 cites
- 1357US2024309015A1Methods for the Treatment of Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 1457US2024124483A1Methods for the Treatment of Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 1555US2023227466A1Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →